AI-Driven Drug Surveillance Platform

Enhancing post-marketing surveillance through advanced AI analysis.

Discover
Adverse Reaction Insights

Identify and classify drug reactions effectively.

Analyze structured and unstructured medical data.

Improve drug safety monitoring processes.

Data Analysis
Real-time Reporting

Innovative AI Drug Surveillance

At Canada Vigilanceras, we enhance drug safety through AI-driven analysis of adverse drug reactions from diverse medical sources for improved patient outcomes.

A surveillance monitor displays a live feed of a subway platform with a few people walking and standing. The monitor is enclosed in a box and situated in a dimly lit area, giving a sense of observation and monitoring in a transportation setting.
A surveillance monitor displays a live feed of a subway platform with a few people walking and standing. The monitor is enclosed in a box and situated in a dimly lit area, giving a sense of observation and monitoring in a transportation setting.
Learn
Several boxes of medication labeled Areplivir are displayed with a blister pack containing tablets in front. The packaging primarily features blue and white colors with some text and branding elements.
Several boxes of medication labeled Areplivir are displayed with a blister pack containing tablets in front. The packaging primarily features blue and white colors with some text and branding elements.
A black object is mounted on a white brick wall with a yellow sticker displaying the word 'DRUGS' in bold letters.
A black object is mounted on a white brick wall with a yellow sticker displaying the word 'DRUGS' in bold letters.

About Canada Vigilanceras

Our platform identifies and classifies adverse drug reactions, ensuring accurate post-marketing surveillance by analyzing structured and unstructured medical data effectively.

AI Drug Surveillance

Enhancing post-marketing surveillance through advanced AI analysis of adverse drug reactions and medical reports.

Reaction Classification

Distinguishing real adverse reactions from incidental reports based on severity and frequency analysis.

A smartphone displaying a rapid antigen test reporting platform application is placed on top of several red and white boxes labeled with 'Rapid SARS-CoV-2 Antigen Test.' The phone screen shows options for different languages and a start button for the application.
A smartphone displaying a rapid antigen test reporting platform application is placed on top of several red and white boxes labeled with 'Rapid SARS-CoV-2 Antigen Test.' The phone screen shows options for different languages and a start button for the application.
Data Analysis

Comprehensive analysis of structured and unstructured data sources to improve drug safety and efficacy.

Several boxes of Areplivir medication are displayed on a clean white surface. Each box features prominent blue and white colors with text in a foreign language. The design includes an image resembling a microscopic view of a virus.
Several boxes of Areplivir medication are displayed on a clean white surface. Each box features prominent blue and white colors with text in a foreign language. The design includes an image resembling a microscopic view of a virus.
gray computer monitor

Contact Us

Reach out for inquiries about our AI drug surveillance platform.

Surveillance

Enhancing drug safety through advanced AI analysis.

Safety

brunopires@canadavigilanceras.sbs

© 2025. All rights reserved.